IBA Annual Conference Copenhagen 2026
4 Oct - 9 Oct 2026
B2 1+3, Level 0
Session information
Rare diseases: strategies for research, development, patient programs, market access and compliance approaches
Tuesday 6 October (0930 - 1045)
B2 1+3, Level 0
Committee(s)
Healthcare and Life Sciences Law Committee
(Lead)
International Commerce and Distribution Committee
Description
Examining comparative global approaches to research, development, patient programs and market access for orphan drugs.
Session / Workshop Chair(s)
| Andrea Abascal | Bofill Mir Abogados, Santiago, Chile; Conference Quality Officer, Healthcare and Life Sciences Law Committee |
Speakers
| Lluis Alcover | Faus & Moliner Abogados SLP, Barcelona, Spain |
| Cristiane Ferreria | Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA |
| Karen Janssens | Lydian, Brussels, Belgium; Junior Membership Officer, Product Law and Advertising Committee |
| Maria Letizia Patania | CMS Adonnino Ascoli & Cavasola Scamoni, Rome, Italy; Chair, International Conventions and Trade Agreements Subcommittee |